Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell suppressive activity

Blood

Volumn 111, Issue 8, 2008, Pages 4233-4244

  Movahedi, Kiavash ^a,b   Guilliams, Martin ^a,b   Van Den Bossche, Jan ^a,b   Van Den Bergh, Rafael ^a,b   Gysemans, Conny ^c   Beschin, Alain ^a,b   De Baetselier, Patrick ^a,b   Van Ginderachter, Jo A ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; NITRIC OXIDE; STAT1 PROTEIN; BIOLOGICAL MARKER; CD11B ANTIGEN; EPITOPE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; FEMALE; LOW DENSITY POLYMORPHONUCLEAR CELL CD11B+ GR1+ MYELOID DERIVED SUPPRESSOR CELL; MACROPHAGE; MONONUCLEAR CELL; MONONUCLEAR CELL CD11B+ GR1+ MYELOID DERIVED SUPPRESSOR CELL; MOUSE; NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; SUPPRESSOR CELL; T LYMPHOCYTE; TUMOR; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL LINE; CYTOLOGY; IMMUNOLOGY; KINETICS; LYMPHOCYTE ACTIVATION; METABOLISM; NEOPLASM; PATHOLOGY; PHENOTYPE; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; SPLEEN; STEM CELL;

ANIMALS; ANTIGENS, CD11B; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINE; EPITOPES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; INTERFERON TYPE II; KINETICS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MYELOID CELLS; NEOPLASMS; PHENOTYPE; SIGNAL TRANSDUCTION; SPLEEN; STEM CELLS; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 43249130187     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-07-099226     Document Type: Article

References (48)

1. Rabinovich GA, Gabrilovich D, Sotomayor EM. Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol. 2007;25:267-296.
2. Bronte V, Apolloni E, CabrelleA, et al. Identification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+)Tcells. Blood. 2000;96:3838-3846.
3. Gallina G, Dolcetti L, Serafini P, et al. Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. J Clin Invest. 2006;116:2777-2790.
4. Gabrilovich Dl, Velders MP, Sotomayor EM. Kast WM. Mechanism of immune dysfunction in cancer mediated by immature Gr-1 + myeloid cells. J Immunol. 2001;166:5398-5406.
5. Kusmartsev S, Nefedova Y. Yoder D. Gabrilovich Dl. Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J Immunol. 2004;172:989-999.6. Kusmartsev S, Nagaraj S, Gabrilovich Dl. Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells. J Immunol. 2005;175:4583-4592.
6. Zea AH, Rodriguez PC, Atkins MB, et al . Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res. 2005;65:3044-3048.
7. Huang B, Pan PY, Li Q, et al. Gr-1 +CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res.2006;66:1123-1131.
8. Liu Y, Van Ginderachter JA, Brys L, De Baetselier P. Raes G, Geldhof AB. Nitric oxide-independent CTLsuppression during tumor progression: association with arginase-producing (M2) myeloid cells. J Immunol. 2003;170:5064-5074.
9. Van Ginderachter JA, Movahedi K, Hassanzadeh Ghassabeh G, et al. Classical and alternative ac-tivation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Imrnuno-biology. 2006;211:487-501.
10. Gabrilovich Dl Bronte V, Chen SH, et al. The terminology issue for myeloid-derived suppressor cells [letter]. Cancer Res. 2007;67:425, author reply 426.
11. Van Ginderachter JA, Meerschaut S, Liu Y, et al. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands reverse CTLsuppression by alternatively activated (M2) macrophages in cancer. Blood. 2006;108:525-535.
12. Bronte V, Chappell DB, Apolloni E, et al. Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+Tcell responses by dysregulating antigen-presenting cell maturation. J Immunol. 1999;162:5728-5737.
13. Melani C, Chiodoni C, Forni G, Colombo MP. Myeloid cell expansion elicited by the progression of spontaneous mammary carcinomas in c-erbB-2 transgenic BALB/c mice suppresses immune reactivity. Blood. 2003;102:2138-2145.
14. Huang Y, Chen X, Dikov MM, et al. Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hema-topoiesis associated with elevated levels of VEGF. Blood. 2007;110:624-631.
15. Bunt SK, Sinha P, Clements VK, Leips J, Ostrand-Rosenberg S. Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J Immunol. 2006;176:284-290.
16. Song X, Krelin Y, DvorkinT, et al. CD11b+/Gr-1 +immature myeloid cells mediate suppression of T cells in mice bearing tumors of IL-1 beta-secreting cells. J Immunol. 2005;175:8200-8208.
17. Sinha P, Clements VK, Fulton AM, Ostrand-Rosenberg S. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res. 2007;67:4507-4513.
18. Bronte V, Zanovello P. Regulation of immune re-sponses by L-arginine metabolism. Nat Rev Immunol. 2005;5:641-654.
19. Bronte V, Serafini P, De Santo C, et al. IL-4-induced arginase 1 suppresses alloreaGtiveT cells in tumor-bearing mice. J Immunol. 2003;170:270-278.
20. Vanden DriesscheT,Verschueren H. De Baetse-lier P. Association between MHC class I antigen expression and malignancy of murine T lymphoma variants. Invasion Metastasis. 1990;10:65-85.
21. Moore MW, Carbone FR, Bevan MJ. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell. 1988;54:777-785.
22. Rossner S, Voigtlander C, Wiethe C, Hanig J, Seitarth C, Lutz MB. Myeloid dendritic cell precursors generated from bone marrow suppress T cell responses via cell contact and nitric oxide production in vitro. Eur J Immunol. 2005;35:3533-3544.
23. Monteiro JP, Benjamin A, Costa ES, Barcinski MA, BonomoA. Normal hematopoiesis is maintained by activated bone marrow CD4+ Tcells. Blood. 2005;105:1484-1491.
24. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19:71-82.
25. Sunderkotter C, NikolicT, Dillon MJ, et al. Sub-populations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol. 2004;172:4410-4417.
26. De Palma M, Venneri MA, Galli R, et al. Tie2 identifies a hematopoietic lineage of proangio-genic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell. 2005;8:211-226.
27. Taylor PR, Brown GD, Geldhof AB, Martinez-Pomares L, Gordon S. Pattern recognition receptors and differentiation antigens define murine myeloid cell heterogeneity ex vivo. Eur J Immu-nol .2003;33:2090-2097.
28. Voehringer D, Shinkai K, Locksley RM. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity. 2004;20:267-277.
29. Gouon-Evans V, Lin EY, Pollard JW. Requirement of macrophages and eosinophils and their cyto-kines/chemokines for mammary gland development. Breast Cancer Res. 2002;4:155-164.
30. Koller BH, Marrack P, Kappler JW, Smithies O. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ Tcells. Science. 1990;248:1227-1230.
31. Xiong H, Zhu C, Li H. et al. Complex formation of the interferon (IFN) consensus sequence-binding protein with IRF-1 is essential for murine macrophage IFN-gamma-induced iNOS gene expression. J Biol Chem. 2003;278:2271-2277.
32. Blanco JC, Contursi C, Salkowski CA, DeWitt DL, Ozato K, Vogel SN. Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon gamma-dependent cyclooxygenase 2 expression. J Exp Med. 2000;191:2131-2144.
33. Eklund EA, Kakar R. Recruitment of CREB-binding protein by PU. 1, IFN-regulatory factor-1, and the IFN consensus sequence-binding protein is necessary for IFN-gamma-induced p67phox and gp91 phox expression. J Immunol. 1999;163:6095-6105.
34. Ramana CV, Gil MP, Han Y Ransohoff RM, SchreiberRD, Stark GR. Statl -independent regulation of gene expression in response to IFN-gamma. Proc Natl Acad Sci USA. 2001 ;98:6674-6679.
35. Gil MP, Bohn E, O'Guin AK, etal. Biologic consequences of Stat1-independent IFN signaling. Proc Natl Acad Sci U S A. 2001;98:6680-6685.
36. Kusmartsev S, Gabrilovich Dl. STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. J Immunol. 2005; 174:4880-4891.
37. Tsuda Y, Takahashi H, Kobayashi M, HanatusaT, Herndon DN, Suzuki F. Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Immunity. 2004;21:215-226.
38. Schmielau J, Finn OJ. Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. Cancer Res. 2001;61:4756-4760.
39. Vasconcelos ZF, Santos BM, Costa ES, et al. T-lymphocyte function from peripheral blood stem-cell donors is inhibited by activated granulocytes. Cytotherapy. 2003;5:336-345.
40. Hacbarth E, Kajdacsy-Balla A. Low density neutrophils in patients with systemic lupus erythematosus, rheumatoid arthritis, and acute rheumatic fever. Arthritis Rheum. 1986;29:1334-1342.
41. Yang R, Cai Z, Zhang Y Yutzy WHt Roby KF, Ro-den RB. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1 +CD11b+myeloid cells. Cancer Res. 2006;66:6807-6815.
42. Vasconcelos ZF Dos Santos BM, Farache J, et al. G-CSF-treated granulocytes inhibit acute graft-versus-host disease. Blood. 2006;107:2192-2199.
43. Sinha P, Clements VK, Bunt SK; Albelda SM, Ostrand-Rosenberg S. Cross-talk between Myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol. 2007;179:977-983.
44. SamardzicT Jankovic V, Stosic-Grujicic S, Trajkovic V. STAT1 is required tor iNOS activation, but not IL-6 production in murine fibroblasts. Cytokine. 2001 ;13:179-182.
45. Martinelli S, Urosevic M, Daryadel A, et al. Induction of genes mediating interferon-dependent extracellular trap formation during neutrophil differentiation. J Biol Chem. 2004;279:44123-44132.
46. Yang L, DeBusk LM, Fukuda K, et al. Expansion of myeloid immune suppressor Gr+CD11 b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell. 2004;6:409-421.
47. Park SJ, NakagawaT, Kitamura H, et al. IL-6 regulates in vivo dendritic cell differentiation through STATS activation. J Immunol. 2004;173:3844-3854.
48. Gabrilovich D, IshidaT, OyamaT, et al. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood. 1998;92:4150-4166.